Evidence map›Paper›PMID 35144021›Full record

ArticleOphthalmology. Retina2022

Impact of Coronavirus Disease 2019 Restrictions on Retinal Detachment: A Multicenter Experience.

Jesse J Jung, Jonathan S Chang, Patrick R Oellers, Mohsin H Ali, Brian K Do, Joseph J Tseng, Roberto Roizenblatt, Rajeev H Muni, Christina Y Weng, Zackery B Oakey and 5 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Ophthalmology. Retina, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Jesse J JungEast Bay Retina Consultants, Inc, Oakland, California; Department of Ophthalmology, University of California, San Francisco, San Francisco, California. Electronic address: jung.jesse@gmail.com.
Jonathan S ChangDepartment of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Patrick R OellersRetina-Vitreous Surgeons of Central New York, Liverpool, New York.
Mohsin H AliRetina Group of Washington, Fairfax, Virginia.
Brian K DoRetina Group of Washington, Fairfax, Virginia.
Joseph J TsengRetina Associates of New York, New York, New York; Department of Ophthalmology, State University of New York, Downstate Health Sciences University, New York, New York.
Roberto RoizenblattSouth Coast Retina Center, Torrance, California.
Rajeev H MuniDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.
Christina Y WengCullen Eye Institute, Baylor College of Medicine, Houston, Texas.
Zackery B OakeyMedical Consultants of Southern California, Rancho Cucamonga, California.
Sean W TsaoDepartment of Ophthalmology, Southern California Permanente Medical Group, Irvine, California.
Soraya RofaghaEast Bay Retina Consultants, Inc, Oakland, California; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
Xavier ChanSingapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, Singapore.
Quan V HoangSingapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, Singapore; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia College of Physicians and Surgeons, New York, New York.
Young Retina Forum
Elman Retina Group · USUniversity of California, San Francisco · USBaylor College of Medicine · USNational University of Singapore · SGRetina Vitreous Associates of Florida · USSingapore National Eye Center · SGState University of New York · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this retrospective, multicenter study of 261 eyes (259 patients), patients who underwent rhegmatogenous retinal detachment repair during the coronavirus disease 2019 (COVID-19) post-lockdown period experienced an additional 22-day delay, leading to significantly more epiretinal membrane and proliferative vitreoretinopathy and lower single-surgery anatomic success rates. During lockdown, perfluoropropane gas was used more commonly, and pneumatic retinopexy was used more commonly in COVID-19-positive patients.

Indexed as

COVID-19Retinal DetachmentCommunicable Disease ControlHumansRetrospective StudiesTreatment OutcomeVisual AcuityCOVID-19LockdownPractice patternsProliferative vitreoretinopathyRhegmatogenous retinal detachment

Identifiers

PMID35144021
PMCPMC8820022
OpenAlexW4210839808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.